MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-MH-19-0199268
Taj Pharmaceuticals Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹6.31 Cr
▲ 31% YoY
Net profit · FY 2024
₹10.69 Lakh
Net margin 1.7%
EBITDA · FY 2024
₹1.3 Cr
EBITDA margin 20.5%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.05 Cr
Issued & subscribed
Open charges
₹4 Cr
Secured borrowings
Company age
22 yrs
Est. 2004
Directors on board
3
As per MCA filings
About Taj Pharmaceuticals Limited
Data last updated:
Taj Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 November 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PLC149424. Its GSTIN is 27AACCT1480C1ZN (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.05 Cr. It is led by directors including Ranvir Kumar Bindeshwari Singh and Abhishek Ranvir Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 214 2nd Floor Bake House No. 16/22 Maharashtra Chamber Of Commerce Lane Fo, Rt, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.31 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹10.69 Lakh (net margin 1.7%) and EBITDA of ₹1.3 Cr (EBITDA margin 20.5%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 3% over five years.
The company is associated with 5 brands: Norvelzo, Taj API, Taj Oncology, Taj Pharma Group and Taj Generics. As per MCA filings, the company has open charges of ₹4 Cr on record. Court records list 82 cases involving the company, including 31 filed by the company and 51 filed against it; 10 cases are pending.
Taj Pharmaceuticals Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0199268). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tajpharma.com.
Company details
CIN U24230MH2004PLC149424
Registration Number 149424
Incorporation Date 05 November 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0199268
CIN history
Taj Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230MH2004PTC149424. The current CIN is U24230MH2004PLC149424, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2004PLC149424 | Current |
| U24230MH2004PTC149424 | Previous |
Key People
Ranvir Kumar Bindeshwari Singh Director Abhishek Ranvir Singh Director Sudheer Singh Director Recognitions & Rankings of Taj Pharmaceuticals
Contact details
Taj Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is tajpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address214 2nd Floor Bake House No. 16/22 Maharashtra Chamber Of Commerce Lane Fo, Rt, Mumbai, Maharashtra, India – 400001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Taj Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Taj Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Taj Pharmaceuticals operates multiple associated brands including NORVELZO, Taj API, and Taj Oncology. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Serves as a distributor of generic pharmaceutical drugs to healthcare providers. | norvelzo.com | |
| Manufactures APIs compliant with US, British, European, Chinese, and Japanese pharmacopoeia. | tajapi.com | |
| Manufacturer of generic oncology products and biosimilars in India. | tajoncology.com | |
| Pharmaceutical manufacturing, generics, and healthcare services in India. | tajpharmagroup.com | |
| Generic pharmaceuticals manufacturing and distribution in India. | tajgenerics.com |
Business activity
The main business activity of Taj Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Taj Pharmaceuticals Limited, buy the company report.
Financials of Taj Pharmaceuticals Limited
FY 2024 filings availableTaj Pharmaceuticals Limited reported revenue of ₹6.31 Cr (up 31% YoY) for FY 2024.
Revenue · FY 2024
₹6.31 Cr ▲ 31%
Net profit · FY 2024
₹10.69 Lakh margin 1.7%
EBITDA · FY 2024
₹1.3 Cr margin 20.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 23%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 167%
3 years · compounded
▲ 88%
5 years · compounded
▲ 47%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 31% growth in the latest year. EBITDA rose 167% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.3 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.5% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Taj Pharmaceuticals Limited, buy the company report.
Board of directors of Taj Pharmaceuticals Limited
Taj Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranvir Kumar Bindeshwari Singh Also directs: Taj Serum Institute LLP, Taj Pharma Healthcare LLP, Arcelor Petroleum Limited and 5 more | Director | 05 Nov 2004 | 21 Years 11 Months | Current |
| Abhishek Ranvir Singh Also directs: Arcelor Petroleum Limited, Arcelor Chemicals Private Limited, Mulberry Chemicals Private Limited and 5 more | Director | 10 Mar 2009 | 17 Years 7 Months | Current |
| Sudheer Singh Also directs: Apollo Life Sciences Private Limited | Director | 21 May 2013 | 13 Years 5 Months | Current |
Peer comparison
Taj Pharmaceuticals Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Green Waves Private Limited | ₹6.33 Cr (FY 2025) | 13.0% | Bhubaneswar, Odisha, India | |||
| Krosyl Pharmaceuticals Private Limited | ₹6.32 Cr (FY 2024) | -45.0% | Vadodara, Gujarat, India | |||
| Taj Pharmaceuticals Limitedthis company | ₹6.31 Cr (FY 2024) | ₹10.69 Lakh | 1.7% | 31.0% | Mumbai, Maharashtra, India | |
| Easom Chemiques Private Limited | ₹6.3 Cr (FY 2025) | 9.0% | Gurgaon, Haryana, India | |||
| Medicef Pharma Limited | ₹6.28 Cr (FY 2024) | Kasauli, Himachal Pradesh, India |
To see the full peer comparison of Taj Pharmaceuticals Limited, buy the company report.
Auditor
Taj Pharmaceuticals Limited is audited by HEMAL PARIKH & CO. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HEMAL PARIKH & CO. LLP | FY 2023 | 133155W/W100297 |
Shareholding
The shareholding of Taj Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Taj Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹4 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Feb 2024 | 100882873 | Indian Overseas Bank | ₹4 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Taj Pharmaceuticals Limited has 82 court cases on record: 31 filed by Taj Pharmaceuticals, 51 filed against it. 10 cases are pending and 72 are disposed.
Total cases
82
Filed by the company
31
Filed against the company
51
Pending
10
Disposed
72
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 44 | 27 | 4 |
| High courts | 36 | 24 | 6 |
| Supreme Court | 2 | 0 | 0 |
Cases on record (5 of 82)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Execution petition | Filed against the company by Kilitch Drugs (India) Ltd. | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Boehringer Ingelheim (India) Pvt.Ltd. and 1 other | Pending |
| Bombay High Court | Court case (S) | Filed against the company by Emcure Pharmaceuticals Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Emcure Pharmaceuticals Limited | Pending |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by Novartis Healthcare Pvt.Limited and 1 other | Disposed |
To see the full case history of Taj Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Taj Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Taj Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCT1480C1ZN | Maharashtra | Active | 01 Jul 2017 |
| 24AACCT1480C1ZT | Gujarat | Active | 15 Nov 2017 |
To see the full GST registrations and return filing status of Taj Pharmaceuticals Limited, buy the company report.
Recent activity
Taj Pharmaceuticals Limited has 9 board changes on record since 2004: 6 appointments and 3 cessations. The latest: Priyanka Singh ceased to be Director on 24 Mar 2015.
AGM
Taj Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Taj Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Indian Overseas Bank amounted to Rs. 4.00 Cr with Charge ID 100882873 was registered on 13 Feb 2024.
Ceased
Priyanka Singh ceased to be Director.
Ceased
Shantanu Kumar Singh ceased to be Director.
Appointed
Sudheer Singh was appointed as Director.
Ceased
Sushma Singh ceased to be Director.
Appointed
Shantanu Kumar Singh was appointed as Director.
Appointed
Abhishek Ranvir Singh was appointed as Director.
Appointed
Priyanka Singh was appointed as Director.
Appointed
Ranvir Kumar Bindeshwari Singh was appointed as Director.
Appointed
Sushma Singh was appointed as Director.
1 earlier event is in the company report.
News
Frequently asked questions
Taj Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 November 2004 (22+ years old) and is registered under CIN U24230MH2004PLC149424.
Taj Pharmaceuticals has 3 current directors:
- Ranvir Kumar Bindeshwari Singh - Director
- Abhishek Ranvir Singh - Director
- Sudheer Singh - Director
The latest financial statements of Taj Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Taj Pharmaceuticals is 27AACCT1480C1ZN, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AACCT1480C1ZT (Gujarat).
The CIN (Corporate Identification Number) of Taj Pharmaceuticals is U24230MH2004PLC149424. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Taj Pharmaceuticals has 82 court cases on record: 31 filed by the company and 51 filed against it. 10 are pending. Most are in the district courts.
Taj Pharmaceuticals was incorporated on 05 November 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Taj Pharmaceuticals by revenue are Green Waves Private Limited, Krosyl Pharmaceuticals Private Limited, Easom Chemiques Private Limited, Medicef Pharma Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Priyanka Singh ceased to be Director on 24 Mar 2015. Shantanu Kumar Singh ceased to be Director on 16 Jul 2013. Sudheer Singh was appointed as Director on 21 May 2013. Taj Pharmaceuticals has 9 board changes on record in total.
Yes, Taj Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0199268).
Taj Pharmaceuticals can be reached through the website tajpharma.com. Its registered office is in Mumbai, Maharashtra, India.